Mallinckrodt To Sell BioVectra Business For $250 Million, Stock Surges

Shares of Mallinckrodt PLC (MNK) soared 13% in premarket trading Tuesday, after the specialty pharmaceutical company announced a deal to…

You must be a paid subscriber to view this content. To become a new paid subscriber, please go to the REGISTER TAB and choose one of the subscription plans.

error: Content is protected !!
en_USEnglish
en_USEnglish